Our CEO, Sho Okiyama, participated in G1 Global Conference 2020 "Disruptive Evolution Post-COVID-19 : Geopolitics, Business and Society" as a panelist.

Our CEO, Sho Okiyama, participated in Healthcare Venture Knot 2020.

Our CSO, Hiroaki Kato, was interviewed by Japanese Magazine PRESIDENT.

Aillis participated in NVIDIA GPU TECHNOLOGY CONFERENCE (GTC) AI Startup Pavilion.

Our CSO, Hiroaki Kato, gave a presentation at SDGs Mirai Kaigi 2020 Business Conference.

Our CSO, Hiroaki Kato, gave a presentation at Yokohama City University's seminar.

Our CEO, Sho Okiyama, gave a lecture at Waseda Business School.

Our CEO, Sho Okiyama, participated in the 60th annual meeting of The Japanese Respiratory Society.

Our CSO, Hiroaki Kato, gave a presentation at Komatsu University Public Forum.

Our CSO, Hiroaki Kato, was interviewed by Vision and Strategy, August 20.

Our CEO, Sho Okiyama, participated in 21st Century Advanced Medical Consortium

Our COO Tanaka participated in AI medical device development seminar

Our COO, Tanaka, was interviewed by Medical DX.

Our CSO, Hiroaki Kato, participated in an online event by Antaa.

Our CSO, Hiroaki Kato, was interviewed by Medical DX.

Our COO, Daichi Tanaka, contributed an article to Technical Information Institute: "Thinking Healthcare Business in the With-Corona Era".

Aillis was selected as one of the [90+ Artificial Intelligence Startups In Healthcare] by CB Insights.

Aillis was introduced on NIKKEI MJ.

Our CEO, Sho Okiyama, participated in a panel discussion titled "Building an effective HealthTech CEO Covid-19 survival strategy" by Galen Growth.

Our CEO, Sho Okiyama, was interviewed by NIKKEI STYLE.